References
- Murray CJ, Barber RM, Foreman KJ, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–2191.
- Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581–596.
- Hajjaran H, Mousavi P, Burchmore R, et al. Comparative proteomic profiling of Leishmania tropica: investigation of a case infected with simultaneous cutaneous and viscerotropic leishmaniasis by 2-dimentional electrophoresis and mass spectrometry. Iran J Parasitol. 2015;10(3):366–380.
- Kumar R, Engwerda C. Vaccines to prevent leishmaniasis. Clin Transl Immunol. 2014;3(3):e13.
- Hartley MA, Drexler S, Ronet C, et al. The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis. Trends Parasitol. 2014;30(8):412–422.
- Zangger H, Ronet C, Desponds C, et al. Detection of Leishmania RNA virus in Leishmania parasites. Plos Negl Trop Dis. 2013;7(1):e2006.
- Scheffter SM, Ro YT, Chung IK, et al. The complete sequence of Leishmania RNA virus LRV2-1, a virus of an Old World parasite strain. Virology. 1995;212(1):84–90.
- Hajjaran H, Mahdi M, Mohebali M, et al. Detection and molecular identification of leishmania RNA virus (LRV) in Iranian Leishmania species. Arch Virol. 2016;161(12):3385–3390.
- Holakouie-Naieni K, Mostafavi E, Boloorani AD, et al. Reprint of “Spatial modeling of Cutaneous Leishmaniasis in Iran from 1983 to 2013. Acta Trop. 2017;165:90–95.
- Mahmoudzadeh-Niknam H, Ajdary S, Riazi-Rad F, et al. Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran. Trop Med Int Health. 2012;17(11):1335–1344.
- Azizi MH, Bahadori M, Dabiri S, et al. History of Leishmaniasis in Iran from 19th Century Onward. Arch Iran Med. 2016;19(2):153–162.
- Aoun K, Bouratbine A. Cutaneous leishmaniasis in North Africa: a review. Parasite. 2014;21(14):1–9.
- Chaara D, Banuls AL, Haouas N, et al. Comparison of Leishmania killicki (syn. L. tropica) and Leishmania tropica population structure in maghreb by microsatellite typing. Plos Negl Trop Dis. 2015;9(12):e0004204.
- Ebrahimi S, Bordbar A, Rastaghi AR, et al. Spatial distribution of sand fly species (Psychodidae: phlebtominae), ecological niche, and climatic regionalization in zoonotic foci of cutaneous leishmaniasis, southwest of Iran. J Vector Ecol. 2016;41(1):103–109.
- Ajaoud M, Es-Sette N, Charrel RN, et al. Phlebotomus sergenti in a cutaneous leishmaniasis focus in Azilal province (High Atlas, Morocco): molecular detection and genotyping of Leishmania tropica, and feeding behavior. Plos Negl Trop Dis. 2015;9(3):e0003687.
- Hajjaran H, Mohebali M, Teimouri A, et al. Identification and phylogenetic relationship of Iranian strains of various Leishmania species isolated from cutaneous and visceral cases of leishmaniasis based on N-acetylglucosamine-1-phosphate transferase gene. Infect Genet Evol. 2014;26:203–212.
- Bahrami F, Darabi H, Riazi-Rad F, et al. FOXP3 expression and frequency of regulatory T cells in healed individuals from Leishmania major infection and the asymptomatic cases. Hum Immunol. 2014;75(10):1026–1033.
- Ajdary S, Riazi-Rad F, Alimohammadian MH, et al. Immune response to Leishmania antigen in anthroponotic cutaneous leishmaniasis. J Infect. 2009;59(2):139–143.
- Mortazavi H, Sadeghipour P, Taslimi Y, et al. Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity. J Eur Acad Dermatol Venereol. 2016;30(12):2118–2121.
- Ghouila A, Guerfali FZ, Atri C, et al. Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity. Infect Genet Evol. 2017;50:110–120.
- Jeddi F, Mary C, Aoun K, et al. Heterogeneity of molecular resistance patterns in antimony-resistant field isolates of Leishmania species from the western Mediterranean area. Antimicrob Agents Chemother. 2014;58(8):4866–4874.
- Kammoun-Rebai W, Naouar I, Libri V, et al. Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis. BMC Infect Dis. 2016;16(1):1.
- Neghina R, Neghina AM. Leishmaniasis, a global concern for travel medicine. Scand J Infect Dis. 2010;42(8):563–570.
- McDowell MA, Rafati S, Ramalho-Ortigao M, et al. Leishmaniasis: middle East and North Africa research and development priorities. Plos Negl Trop Dis. 2011;5(7):e1219.
- Rafati S, Kamhawi S, Valenzuela JG, et al. Building research and development capacity for neglected tropical diseases impacting leishmaniasis in the middle east and North Africa: a case study. Plos Negl Trop Dis. 2015;9(8):e0003695.